Gambaran Umum
Ono Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in Japan. Established in 1717, the company primarily operates within the pharmaceuticals industry, focusing on the research, development, manufacturing, and sale of drugs. Ono Pharmaceutical is renowned for its innovative contributions to the healthcare sector, with a significant emphasis on oncology, neurology, and immunology. Among its key projects, the company has developed Opdivo, a groundbreaking immunotherapy treatment for several types of cancer. Ono Pharmaceutical is committed to "creating innovative drugs" and "contributing to the health of people worldwide" through its comprehensive research and development efforts.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Ono Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 496,732.00 MM.
- Nilai operating income untuk Ono Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 54,436.00 MM.
- Nilai net income untuk Ono Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 42,926.00 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 496,732.00 | 54,436.00 | 42,926.00 |
2025-03-31 | 486,871.00 | 61,792.00 | 50,047.00 |
2024-12-31 | 487,331.00 | 87,869.00 | 74,025.00 |
2024-09-30 | 484,298.00 | 119,138.00 | 95,127.00 |
2024-06-30 | 500,331.00 | 149,636.00 | 120,953.00 |
2024-03-31 | 502,672.00 | 159,935.00 | 127,977.00 |
2023-12-31 | 498,070.00 | 172,081.00 | 127,611.00 |
2023-09-30 | 489,199.00 | 166,810.00 | 124,875.00 |
2023-06-30 | 460,481.00 | 153,231.00 | 115,064.00 |
2023-03-31 | 447,187.00 | 150,045.00 | 112,723.00 |
2022-12-31 | 428,951.00 | 151,237.00 | 111,555.00 |
2022-09-30 | 403,985.00 | 132,915.00 | 96,568.00 |
2022-06-30 | 380,720.00 | 119,185.00 | 85,922.00 |
2022-03-31 | 361,361.00 | 110,815.00 | 80,519.00 |
2021-12-31 | 345,781.00 | 98,702.00 | 73,558.00 |
2021-09-30 | 332,887.00 | 104,492.00 | 81,866.00 |
2021-06-30 | 321,734.00 | 101,472.00 | 78,003.00 |
2021-03-31 | 309,284.00 | 98,723.00 | 75,425.00 |
2020-12-31 | 302,054.00 | 93,854.00 | 74,364.00 |
2020-09-30 | 293,886.00 | 88,233.00 | 66,737.00 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 157.39 | 157.29 |
2024-09-30 | 201.57 | 201.49 |
2024-06-30 | 254.46 | 254.37 |
2024-03-31 | 266.61 | 266.57 |
2023-12-31 | 263.66 | 263.60 |
2023-09-30 | 256.38 | 256.32 |
2023-06-30 | 235.63 | 235.58 |
2023-03-31 | 230.85 | 230.79 |
2022-12-31 | 228.25 | 228.22 |
2022-09-30 | 196.67 | 196.64 |
2022-06-30 | 174.03 | 174.00 |
2022-03-31 | 162.19 | 162.16 |
2021-12-31 | 147.49 | 147.47 |
2021-09-30 | 164.01 | 163.99 |
2021-06-30 | 156.27 | 156.25 |
2021-03-31 | 151.11 | 151.09 |
2020-12-31 | 148.95 | 148.93 |
2020-09-30 | 133.61 | 133.60 |
2020-06-30 | 129.60 | 129.58 |
2020-03-31 | 118.47 | 118.45 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Ono Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 85,019.00 MM.
- Nilai cash from investing activities untuk Ono Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah -14,632.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Ono Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah -63,313.00 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 85,019.00 | -14,632.00 | -63,313.00 |
2025-03-31 | 82,459.00 | -136,785.00 | 94,299.00 |
2024-12-31 | 92,625.00 | -123,407.00 | 89,107.00 |
2024-09-30 | 108,662.00 | -133,566.00 | 86,486.00 |
2024-06-30 | 121,111.00 | -107,929.00 | 59,543.00 |
2024-03-31 | 110,660.00 | 48,077.00 | -89,848.00 |
2023-12-31 | 106,044.00 | -36,034.00 | -76,970.00 |
2023-09-30 | 115,354.00 | -41,621.00 | -64,066.00 |
2023-06-30 | 116,894.00 | -108,129.00 | -36,665.00 |
2023-03-31 | 159,610.00 | -100,259.00 | -32,484.00 |
2022-12-31 | 149,495.00 | -56,870.00 | -46,875.00 |
2022-09-30 | 102,437.00 | -26,502.00 | -60,334.00 |
2022-06-30 | 88,151.00 | 9,839.00 | -60,316.00 |
2022-03-31 | 61,829.00 | 6,038.00 | -60,237.00 |
2021-12-31 | 53,343.00 | -33,550.00 | -45,362.00 |
2021-09-30 | 83,032.00 | -58,938.00 | -27,234.00 |
2021-06-30 | 70,321.00 | -58,931.00 | -27,227.00 |
2021-03-31 | 73,977.00 | -57,586.00 | -24,754.00 |
2020-12-31 | 72,011.00 | -26,563.00 | -24,956.00 |
2020-09-30 | 70,596.00 | -16,948.00 | -24,991.00 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Ono Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.05.
- roe untuk Ono Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.05.
- roic untuk Ono Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.05.
- croic untuk Ono Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.04.
- ocroic untuk Ono Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.09.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.05 | 0.05 | 0.05 | 0.04 | 0.09 |
2025-03-31 | 0.08 | 0.09 | 0.08 | 0.06 | 0.09 |
2024-12-31 | 0.11 | 0.09 | 0.10 | 0.06 | 0.11 |
2024-09-30 | 0.14 | 0.12 | 0.12 | 0.08 | 0.12 |
2024-06-30 | 0.15 | 0.17 | 0.16 | 0.09 | 0.14 |
2024-03-31 | 0.15 | 0.18 | 0.16 | -0.01 | 0.13 |
2023-12-31 | 0.16 | 0.18 | 0.16 | 0.01 | 0.15 |
2023-09-30 | 0.15 | 0.17 | 0.15 | -0.04 | 0.15 |
2023-06-30 | 0.15 | 0.17 | 0.15 | -0.04 | 0.15 |
2023-03-31 | 0.15 | 0.17 | 0.15 | 0.04 | 0.21 |
2022-12-31 | 0.12 | 0.14 | 0.13 | 0.02 | 0.14 |
2022-09-30 | 0.11 | 0.14 | 0.13 | 0.02 | 0.14 |
2022-06-30 | 0.11 | 0.13 | 0.13 | 0.06 | 0.13 |
2022-03-31 | 0.10 | 0.13 | 0.12 | 0.01 | 0.09 |
2021-12-31 | 0.11 | 0.12 | 0.11 | -0.04 | 0.12 |
2021-09-30 | 0.12 | 0.13 | 0.12 | -0.00 | 0.11 |
2021-06-30 | 0.11 | 0.13 | 0.12 | -0.02 | 0.11 |
2021-03-31 | 0.11 | 0.13 | 0.12 | -0.01 | 0.11 |
2020-12-31 | 0.11 | 0.13 | 0.12 | 0.03 | 0.11 |
2020-09-30 | 0.10 | 0.12 | 0.11 | 0.05 | 0.11 |
2020-06-30 | 0.10 | 0.12 | 0.11 | 0.04 | 0.13 |
2020-03-31 | 0.09 | 0.11 | 0.10 | 0.02 | 0.13 |
Gross Margins
- marjin kotor untuk Ono Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.70.
- marjin bersih untuk Ono Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.10.
- marjin operasi untuk Ono Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.13.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.70 | 0.10 | 0.13 |
2025-03-31 | 0.71 | 0.15 | 0.18 |
2024-12-31 | 0.74 | 0.20 | 0.25 |
2024-09-30 | 0.75 | 0.24 | 0.30 |
2024-06-30 | 0.75 | 0.25 | 0.32 |
2024-03-31 | 0.76 | 0.26 | 0.35 |
2023-12-31 | 0.75 | 0.26 | 0.34 |
2023-09-30 | 0.75 | 0.25 | 0.33 |
2023-06-30 | 0.75 | 0.25 | 0.33 |
2023-03-31 | 0.75 | 0.25 | 0.32 |
2022-12-31 | 0.75 | 0.24 | 0.33 |
2022-09-30 | 0.74 | 0.24 | 0.33 |
2022-06-30 | 0.74 | 0.23 | 0.31 |
2022-03-31 | 0.74 | 0.22 | 0.29 |
2021-12-31 | 0.73 | 0.21 | 0.29 |
2021-09-30 | 0.73 | 0.25 | 0.31 |
2021-06-30 | 0.73 | 0.24 | 0.32 |
2021-03-31 | 0.72 | 0.24 | 0.32 |
2020-12-31 | 0.72 | 0.25 | 0.31 |
2020-09-30 | 0.73 | 0.23 | 0.30 |
2020-06-30 | 0.73 | 0.22 | 0.29 |
2020-03-31 | 0.73 | 0.20 | 0.26 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 940821 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |